← Back to headlines
Sino Biopharm Unit Licenses Blood Cancer Drug to Sanofi for Up to $1.53 Billion - Reuters
Sino Biopharm unit licenses blood cancer drug to Sanofi for up to $1.53 billion Reuters
Sources
Showing 0 of 2 sources
No articles available in your preferred languages.
2 articles available in other languages below.
seeking-alphands158d ago
Sanofi bets up to $1.53B to license blood cancer drug from Sino Biopharma unit
Read full article →ReutersFrench158d ago
Sino Biopharm unit licenses blood cancer drug to Sanofi for up to $1.53 bln - Reuters
Sino Biopharm unit licenses blood cancer drug to Sanofi for up to $1.53 bln Reuters
Read full article →Coverage Timeline
First report: Reuters · 3 Mar, 23:13|Full coverage: 2 · 13h|Window: 13h
Left-leaningCenterRight-leaning
